General project information

WP1 

Management, coordination, dissemination and sustainability

WP2 

Cohorts

WP3

Mechanisms of Immune Tolerance

WP4

Technologies for monitoring the RA-associated immune state

WP6

Clinical studies

WP7

Ethics requirements

WP5 

Bioinformatics and data

  • Follow us on Twitter

Follow us on Twitter:

The RTCure project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement no 777357. This joint undertaking receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA.

The communication reflects the author's view; neither IMI nor the European Union or EFPIA  are responsible for any use that may be made of the information contained herein.